PharmaCyte Biotech, Inc. (PMCB)

Company Overview
Nuvilex is an innovative company which aims at ionitiating a paradigm shift, generating revenue at the same time as creating cancer and other cell related solutions to treat important human diseases, such as pancreatic cancer while retaining our connections to natural products. The present effort underway will give rise to dramatic advances in cancer therapy and benefit millions of people worldwid
read more

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Aug 27, 2015

Hotstocked Precision will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 10:07PM EDT August 27, 2015
$ 0.099   0 (2.06%)
Today's Open: 0.0962 Previous Close: 0.097
Today's High: 0.099 Volume: 1,192,878
Today's Low: 0.0955 Avg Vol: 1,432,698
52 Week High: 0.27 Bid (size): 0
52 Week Low: 0.095 Ask (size): 0

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: Meadows Corporate Park I, 12510 Prosperity Boulevard, Silver Spring, MD 20904, United States
Mailing Address: -
Phone: 240-696-6859
Fax: -
Website: http//www.nuvilex.com

Company Details:

Symbol: PMCB
SIC: -
State location: MD
Sector: -
State of Inc: NV
Employees: 1
Type: -

Key executives:

Name Age Position
2015
Dr. Gerald W. Crabtree 2015 COO
Patricia Gruden 2015 Chairman of the Board of Directors and CFO
Robert F. Ryan 2015 President, CEO

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Aug 27, 2015

This free program will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Gets More Pumps July 13, 2015

After a bout of excitement in mid-April and a couple of recent attempts at recovery, on Friday Pharmacyte Biotech Inc (OTCMKTS:PMCB) sank 10% and returned to just over a dime per share and just a breath above its lowest closing price for the past 52 weeks. read more

Pharmacyte Biotech Inc. (OTCMKTS:PMCB)'s Pump Goes Bad Again July 8, 2015

Pharmacyte Biotech Inc. (OTCMKTS:PMCB)'s slide was interrupted for an all too brief period of time, but now the ticker is glowing red again. read more

Pharmacyte Biotech Inc. (OTCMKTS:PMCB)'s Slide Continues July 6, 2015

Pharmacyte Biotech Inc. (OTCMKTS:PMCB) lost another 5.26% of its market cap last Thursday, dropping below the starting point of its latest ascent. read more

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Pops on New PR June 30, 2015

On Friday Pharmacyte Biotech Inc (OTCMKTS:PMCB) was back to lows of just over $0.10 per share. A press release that the company dropped near the opening bell yesterday reversed its red streak and pushed PMCB to a close 22% in the green. read more

LATEST STOCK PROMOTIONS

ALL Eyes on PMCB Tonight! Jul 08, 2015, 21:43

  Today's pick is: PMCB DEAR VALUED SUBSCRIBERS, Tonight it’s time to focus on what could be one of the hottest Biotech plays of 2015. Yes, that’s a bold statement… but we’re talking about a very bold company… and it operates in the TWO hottest, most active sectors on the small markets: Cannabis and Biotech! If you’ve been with us for a while read more

Promoter: PennyStockLaboratory.com Paying Party: UNKNOWN Max Profit: 14.42% Gain at close: Pending
Stock: pmcb Compensation: $3,000 Avg $ Volume for Period: UNKNOWN

ALL Eyes on PMCB Tonight! Jul 08, 2015, 21:41

  The #1 Newsletter for Highly Profitable Penny Stock Alerts Today's pick is: PMCB Dear Valued Subscribers: Tonight it’s time to focus on what could be one of the hottest Biotech plays of 2015. Yes, that’s a bold statement… but we’re talking about a very bold company… and it operates in the TWO hottest, most active sectors on the small markets: read more

Promoter: PennyStockInformer.com Paying Party: UNKNOWN Max Profit: 14.42% Gain at close: Pending
Stock: pmcb Compensation: $3,000 Avg $ Volume for Period: UNKNOWN

PMCB finds technical support, major bounce coming Jul 08, 2015, 20:01

    PharmaCyte Biotech Inc (PMCB)     Subscribers,   Although 10% gains were technically possible, today's play gapped up too much so it didn't have much room to run. So tomorrow its back to an old favorite that we've banked on several times. And the chart setup looks great.   PMCB is a highly liquid trader that has pulled back right to multi-month technical support.    We think there could be strong read more

Promoter: Stock Shock and Awe Paying Party: UNKNOWN Max Profit: 14.42% Gain at close: Pending
Stock: pmcb Compensation: $2,000 Avg $ Volume for Period: UNKNOWN

Nuvilex, Inc. (NVLX) MESSAGE BOARD

Post # Subject Re Name Date
1 Such a deep anewsr! GD&RVVF 0
2 I love these areltics. How many words can... 0
3 Well, I think the Fed has to do a lot... 0
4 I just love how optimistic Jim Cramer and... 0
5 Dear Minamar,Can you give me some more... 0
6 Well mamiadcaa nuts, how about that. 0
7 I hope so 0
8 I'm a Dollarniare now! The scams on otc... 0
9 yes we are ging to be millionaires but it... 1
10 chemo kills weed does not 0
11 What happened to this stock today? It's... 0
12 Oh what happened? 2
13 Tanking like a ROCK!! Alpha Articles out!!! 4
14 FDA possible approval response to NVLX... 1
15 Yes it can 0
16 Man! I'd personally write some options... 0
17 20 Ducats? You jest my dear buffoon! 0
18 Oh Sheeheeheeheet! NVLX is fo' real ?... 0
19 50:1 split? Ha ha 0
20 with a 50:1 Reverse stock split! Yes... 0